Paloma Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-659
| Closed | -$277K | – | 129 |
|
|
2025
Q1 | $277K | Buy |
+659
| New | +$286K | 0.03% | 105 |
|
|
2024
Q4 | – | Sell |
-931
| Closed | -$470K | – | 648 |
|
|
2024
Q3 | $470K | Sell |
931
-879
| -49% | -$427K | 0.01% | 643 |
|
|
2024
Q2 | $882K | Buy |
+1,810
| New | +$909K | 0.02% | 556 |
|
|
2023
Q2 | – | Sell |
-237
| Closed | -$114K | – | 845 |
|
|
2023
Q1 | $119K | Buy |
+237
| New | +$113K | ﹤0.01% | 672 |
|
|
2022
Q3 | – | Sell |
-1,400
| Closed | -$514K | – | 1163 |
|
|
2022
Q2 | $491K | Buy |
1,400
+608
| +77% | +$248K | 0.02% | 625 |
|
|
2022
Q1 | $434K | Buy |
+792
| New | +$417K | 0.01% | 870 |
|
|
2021
Q4 | – | Sell |
-1,173
| Closed | -$736K | – | 1988 |
|
|
2021
Q3 | $729K | Buy |
+1,173
| New | +$788K | 0.02% | 434 |
|
|
2021
Q2 | – | Sell |
-8,570
| Closed | -$4.19M | – | 2003 |
|
|
2021
Q1 | $4.19M | Buy |
+8,570
| New | +$4.29M | 0.09% | 184 |
|
|
2020
Q4 | – | Sell |
-3,484
| Closed | -$1.37M | – | 1906 |
|
|
2020
Q3 | $1.37M | Buy |
+3,484
| New | +$1.29M | 0.03% | 548 |
|
|
2018
Q4 | – | Sell |
-7,582
| Closed | -$1.89M | – | 1502 |
|
|
2018
Q3 | $1.89M | Buy |
+7,582
| New | +$1.84M | 0.03% | 477 |
|
|
2018
Q2 | – | Sell |
-5,712
| Closed | -$1.09M | – | 1897 |
|
|
2018
Q1 | $1.09M | Sell |
5,712
-8,092
| -59% | -$1.49M | 0.02% | 944 |
|
|
2017
Q4 | $2.16M | Buy |
13,804
+807
| +6% | +$127K | 0.03% | 634 |
|
|
2017
Q3 | $2.02M | Sell |
12,997
-7,603
| -37% | -$1.2M | 0.03% | 733 |
|
|
2017
Q2 | $3.33M | Buy |
20,600
+17,700
| +610% | +$2.87M | 0.04% | 470 |
|
|
2017
Q1 | $448K | Sell |
2,900
-16,674
| -85% | -$2.3M | 0.01% | 1619 |
|
|
2016
Q4 | $2.29M | Buy |
19,574
+10,411
| +114% | +$1.19M | 0.02% | 598 |
|
|
2016
Q3 | $1.03M | Sell |
9,163
-20,485
| -69% | -$2.16M | 0.01% | 988 |
|
|
2016
Q2 | $2.75M | Buy |
29,648
+5,560
| +23% | +$477K | 0.03% | 522 |
|
|
2016
Q1 | $1.89M | Buy |
24,088
+18,155
| +306% | +$1.31M | 0.03% | 512 |
|
|
2015
Q4 | $433K | Sell |
5,933
-62,791
| -91% | -$4.48M | 0.01% | 1117 |
|
|
2015
Q3 | $5.1M | Buy |
+68,724
| New | +$4.92M | 0.12% | 106 |
|
|
2015
Q1 | – | Sell |
-41,970
| Closed | -$3.11M | – | 1299 |
|
|
2014
Q4 | $3.11M | Buy |
+41,970
| New | +$2.94M | 0.13% | 158 |
|
|
2014
Q2 | – | Sell |
-6,880
| Closed | -$418K | – | 1153 |
|
|
2014
Q1 | $418K | Buy |
+6,880
| New | +$410K | 0.03% | 453 |
|
|
2013
Q4 | – | Sell |
-8,772
| Closed | -$437K | – | 1078 |
|
|
2013
Q3 | $437K | Buy |
8,772
+2,016
| +30% | +$96.9K | 0.02% | 527 |
|
|
2013
Q2 | $303K | Buy |
+6,756
| New | +$295K | 0.02% | 647 |
|
Other funds holding IDXX
Paloma Partners's IDXX Position: Q2 2025 in Review
Paloma Partners sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 659 shares — an estimated $277K sold.
Paloma Partners first reported a position in IDXX in Q2 2013 and held it in 25 quarters. The position peaked at $5.1M in Q3 2015. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.
- Paloma Partners reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
- Paloma Partners sold 659 Idexx Laboratories shares in Q2 2025, an estimated $277K.
- Paloma Partners first reported a position in Idexx Laboratories in Q2 2013 and held it in 25 quarters.
- Paloma Partners's Idexx Laboratories position peaked at $5.1M in Q3 2015.
- 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.
Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.